ALMR · TickerCove

ALMRAlamar Biosciences, Inc.Healthcare · Biotechnologyas of 2026-09-16

Horizon

Issued 2026-09-16 at $29.38 · now $29.38 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, ALMR has typically landed between $23.47 and $42.44 — a range of −20.1% to +44.5% from the issuance price $29.38.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.

Actual close
Typical path (median)
Middle 50% of outcomes
90% range

84 overlapping 1 month windows · 2026-04-17 – 2026-08-17 · basis climatology · forecast (batch).

The cone is anchored at the 2026-09-16 issuance close ($29.38) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

52-week range$29.38 · 59% of range

$19.09 low$36.57 high

Trailing 52 weeks to 2026-09-16 — factual context, not a signal.

Distribution ranges onlyiThis name has too little trading history to publish a calibrated probability, so we show its distribution ranges only — no directional call. Its record is still building.

No directional probability — ranges below.

Distribution · month iiThe price-anchored range: typical move (median), and the p90 downside/upside — 90% of similar periods stayed inside these. Ranges, not a prediction of direction.

+8.5%

typical move · IQR 32.8%

−20.1%worst (p90)+44.5%best (p90)

Insider convictioniOpen-market common-stock purchases by company insiders in the last 90 days (grants and option exercises excluded). Historical tendency, not advice — detail below.

conviction buys

0 open-market sales

Congress disclosuresiRecent disclosed congressional trades for this company. Purchase clusters (≥2 members buying within 90 days) historically preceded a modestly higher forward return (+32 bp/mo in 2022–2026, +45 bp/mo in 2015–2021) — a descriptive tendency, not a forecast input. Detail below.

0 buys · 0 sells · 0 members

cluster tilt persisted, ~halved after 2021

Where ALMR has typically landed a month from the 2026-09-16 close of $29.38 — the range is history, not a prediction.

now $29.38 (+0.0%)
typical $31.89 (+8.5%)
middle 50% $27.07–$36.7
90% range $23.47–$42.44

Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 84 windows spanning 2026-04-17 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.

Start	Return	Max drop	Max rise
3 worst
2026-04-27	−28.4%	−28.5%	+0.0%
2026-04-28	−24.3%	−26.9%	+0.0%
2026-08-11	−24.1%	−24.1%	+0.0%
3 best
2026-07-21	+41.3%	−3.1%	+45.4%
2026-06-09	+41.2%	−0.3%	+41.2%
2026-05-26	+40.8%	+0.0%	+40.8%

84 overlapping windows · 2026-04-17 – 2026-09-16 · not cherry-picked

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Date	Person	Role	Action	Shares @ price	Value	Ownership Δ	vs S&P 1m	vs S&P 6m	Owned after	Filing
2026-04-20	Illumina Innovation Fund II GP, L.L.C.	tenPercentOwner	Purchase	235,294 @ $17.00	$4.0M	+86.6% of holding	−10.3%	not yet — horizon still open	507,076	Form 4 · filed same day
2026-04-20	Naclerio Nicholas	director	Purchase	235,294 @ $17.00	$4.0M	+86.6% of holding	−10.3%	not yet — horizon still open	507,076	Form 4 · filed same day

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

266 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

Date	Person	Role	Action	Shares	Owned after	Filing
2026-09-14	Brottem John L.	officer	Award / grant	85,000	85,000	Form 4
2026-09-14	Brottem John L.	officer	Award / grant	29,000	29,000	Form 4
2026-09-01	RAGUSA ROBERT P	director	Award / grant	25,599	25,599	Form 4
2026-09-01	RAGUSA ROBERT P	director	Award / grant	5,686	5,686	Form 4
2026-04-20	Illumina Innovation Fund II GP, L.L.C.	tenPercentOwner	Conversion	3,194,377	0	Form 4
2026-04-20	Illumina Innovation Fund II GP, L.L.C.	tenPercentOwner	Conversion	2,862,507	0	Form 4
2026-04-20	Witney Frank	director	Other acquisition	124,069	0	Form 4
2026-04-20	Witney Frank	director	Other acquisition	124,069	124,069	Form 4
2026-04-20	Luo Yuling	director	Award / grant	76,509	1,940,574	Form 4
2026-04-20	Illumina Innovation Fund II GP, L.L.C.	tenPercentOwner	Conversion	2,094,266	0	Form 4
2026-04-20	Illumina Innovation Fund II GP, L.L.C.	tenPercentOwner	Conversion	5,037,783	0	Form 4
2026-04-20	Luo Yuling	director	Other acquisition	266,311	266,311	Form 4
2026-04-20	Luo Yuling	director	Other acquisition	25,310	0	Form 4
2026-04-20	Luo Yuling	director	Other acquisition	1,033,912	0	Form 4
2026-04-20	Luo Yuling	director	Other acquisition	1,033,912	1,033,912	Form 4
2026-04-20	Luo Yuling	director	Other acquisition	37,086	0	Form 4
2026-04-20	Luo Yuling	director	Other acquisition	37,086	37,086	Form 4
2026-04-20	Luo Yuling	director	Other acquisition	42,334	0	Form 4
2026-04-20	Luo Yuling	director	Other acquisition	42,334	42,334	Form 4
2026-04-20	Luo Yuling	director	Other acquisition	27,700	0	Form 4
2026-04-20	Chen Shiping	director	Other acquisition	300,883	300,883	Form 4
2026-04-20	Chen Shiping	director	Other acquisition	12,190	0	Form 4
2026-04-20	Chen Shiping	director	Other acquisition	722,885	722,885	Form 4
2026-04-20	Chen Shiping	director	Award / grant	37,220	760,105	Form 4
2026-04-20	Qiming Corporate GP VI, Ltd.	tenPercentOwner	Conversion	4,222,738	0	Form 4
2026-04-20	Chen Shiping	director	Conversion	247,311	0	Form 4
2026-04-20	Chen Shiping	director	Conversion	73,200	0	Form 4
2026-04-20	Chen Shiping	director	Conversion	176,160	0	Form 4
2026-04-20	Chen Shiping	director	Other acquisition	300,883	0	Form 4
2026-04-20	Chen Shiping	director	Other acquisition	12,190	12,190	Form 4
2026-04-20	Luo Yuling	director	Conversion	1,020,742	0	Form 4
2026-04-20	Luo Yuling	director	Conversion	366,004	0	Form 4
2026-04-20	Luo Yuling	director	Conversion	880,802	0	Form 4
2026-04-20	Luo Yuling	director	Conversion	1,224,152	0	Form 4
2026-04-20	Luo Yuling	director	Other acquisition	25,310	25,310	Form 4
2026-04-20	Luo Yuling	director	Other acquisition	23,986	0	Form 4
2026-04-20	Witney Frank	director	Other acquisition	49,627	0	Form 4
2026-04-20	Witney Frank	director	Other acquisition	49,627	49,627	Form 4
2026-04-20	Witney Frank	director	Other acquisition	33,085	0	Form 4
2026-04-20	Witney Frank	director	Other acquisition	33,085	33,085	Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Resolves in i

28d remaining

2026-09-173% elapsed2026-10-15

Logged immutably 2026-09-17; scored automatically on 2026-10-15 — no edits, ever.

Earnings & context analysis

These panels are being prepared. They are generated by multiple language models, checked, and stored before display — never written live for a page view. Until a model panel has been generated and reviewed for a company, nothing is shown here, honestly, rather than a placeholder.

Calibration i

Every forecast is logged when made and scored when the month is up. The record is shown from the day it starts — young and honest.

How scoring works →

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.